03 Profile
Vital Signsby Bridgehead
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Susana Zaph: no licensed photograph is held, so the academic plate is shown instead.
Academic
Susana Zaph
Ph.D., U.S. head of QSP at Sanofi
1
0
0
0
0
0
0
0
Apr 2026MayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 17 Apr 2026 · last quoted 17 Apr 2026
02 Quoted on · 1 of 29 topics
Susana Zaph: key facts
- Kind of voice
- Academic
- Role
- Ph.D., U.S. head of QSP at Sanofi
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 17 Apr 2026
04 The signal · where Susana Zaph sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=David MargolinAcademicM.D., Ph.D., VP of clinical development at uniQure1
- 25=Kelley KidwellAcademicPh.D., University of Michigan biostatistician1
- 25=Susana ZaphAcademicPh.D., U.S. head of QSP at Sanofi1
- 25=Wonyul LeeAcademicPh.D., senior statistical reviewer at CDER1
- 25=Dr Whitney ThompsonAcademicScientist at Mayo Clinic1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Susana Zaph has said
By outlet · linked articles
- fiercebiotech.com1
Where Susana Zaph has been quoted
- 01Small pools, big ideas: How the rare disease community is reimagining clinical trialsfiercebiotech.com · 17 Apr 2026
Verbatim
“We basically took a subset of parameters that describe the model and personalized them to be able to capture the very specific biomarker and clinical development profiles of the individual patients to create digital twins, taking into account their body weight and their age”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.